Document
type: Class

Academic Article
type: Class

Continuant
type: Class

Entity
type: Class

individual
rights: termsOfUse
date: 2026-08-24T03:46:37
publisher: http://irises.unisr.it/resource/item/87171
type: Document
label: RDF description of Final results and outcomes by prior bevacizumab exposure, skin toxicity, and hypomagnesaemia from ASPECCT: randomized phase 3 non-inferiority study of panitumumab versus cetuximab in chemorefractory wild-type KRAS exon 2 metastatic colorectal cancer - http://irises.unisr.it/resource/item/87171

Generically Dependent Continuant
type: Class

Article
type: Class

4676989
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: http://irises.unisr.it/resource/item/87171

Inglese
type: Language

Information Content Entity
type: Class

http://irises.unisr.it/resource/item/87171
type: Document
type: Generically Dependent Continuant
label: Final results and outcomes by prior bevacizumab exposure, skin toxicity, and hypomagnesaemia from ASPECCT: randomized phase 3 non-inferiority study of panitumumab versus cetuximab in chemorefractory wild-type KRAS exon 2 metastatic colorectal cancer
most specific type: Academic Article
type: Thing
type: Information Content Entity
language: Inglese
related by: 4676989
type: Entity
type: Continuant
type: Academic Article
type: Article